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Abstract
Alveolar macrophages (AM) are critical for defense against bacterial and fungal infections. However, a definitive role of AM
in viral infections remains unclear. We here report that AM play a key role in survival to influenza and vaccinia virus infection
by maintaining lung function and thereby protecting from asphyxiation. Absence of AM in GM-CSF-deficient (Csf22/2) mice
or selective AM depletion in wild-type mice resulted in impaired gas exchange and fatal hypoxia associated with severe
morbidity to influenza virus infection, while viral clearance was affected moderately. Virus-induced morbidity was far more
severe in Csf22/2 mice lacking AM, as compared to Batf3-deficient mice lacking CD8a+ and CD103+ DCs. Csf22/2 mice
showed intact anti-viral CD8+ T cell responses despite slightly impaired CD103+ DC development. Importantly, selective
reconstitution of AM development in Csf2rb2/2 mice by neonatal transfer of wild-type AM progenitors prevented severe
morbidity and mortality, demonstrating that absence of AM alone is responsible for disease severity in mice lacking GM-CSF
or its receptor. In addition, CD11c-Cre/Ppargfl/fl mice with a defect in AM but normal adaptive immunity showed increased
morbidity and lung failure to influenza virus. Taken together, our results suggest a superior role of AM compared to CD103+
DCs in protection from acute influenza and vaccinia virus infection-induced morbidity and mortality.
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Introduction
Alveolar macrophages (AM) are lung-resident macrophages
important for the maintenance of surfactant homeostasis in the
alveolar space [1]. Their importance for lung physiology becomes
evident in a rare human syndrome termed ‘‘pulmonary alveolar
proteinosis’’ (PAP), which is characterized by the accumulation of
surfactant material and a varying degree of respiratory insuffi-
ciency [2]. PAP patients have a higher risk for pulmonary
infections with opportunistic pathogens [3]. PAP typically occurs
in patients that spontaneously develop GM-CSF autoantibodies
[4] or carrying mutations in the GM-CSF receptor a chain [5]
associated with impaired function and/or reduced numbers of
AM. Similarly, mice lacking GM-CSF (Csf22/2) or the receptor b
chain (Csf2rb2/2) develop PAP [6,7,8,9] and display increased
susceptibility to a range of bacterial and fungal infections, which is
associated with impaired innate functions of AM [10,11,12,13,14].
High phagocytic activity and expression of pattern recognition
receptors provides them with the capacity to respond to bacterial
and fungal pathogens. However, AM were also described to have
anti-inflammatory properties based on direct inhibition of the
antigen-presenting function of lung DCs [15] and production of
immunosuppressive mediators such as IL-10 and nitric oxide [16].
In addition, AM were proposed to sequester pulmonary antigen
and thereby interfere with efficient priming of immune responses
by DCs [17]. In contrast to the well-described functions of AM in
bacterial and fungal infections, their precise role during viral
infections is poorly understood. AM have the capacity to
endocytose adenovirus particles, which was impaired in cells
isolated from Csf2-deficient mice [10]. Furthermore, AM are
potent producers of type I IFNs upon pulmonary virus infection
[18,19]. A beneficial role of AM in influenza infection has been
proposed based on AM depletion experiments [20,21,22] and
treatment of mice with GM-CSF that increased numbers of AM
[23,24]. However, besides the described role of GM-CSF for AM
function under steady-state conditions, GM-CSF also influences
DCs as demonstrated by its positive effects on the homeostasis of
CD103+ DCs [25] or the upregulation of CD103 on CD11b2
DCs [26]. Indeed, a recent report proposed that GM-CSF protects
from lethal influenza virus infection by enhancing CD103+ DC
mediated anti-viral T cell responses [27].
In this study, we revisited these controversies by comparing DC
subpopulations and anti-viral CD8+ T cell responses in the
presence or absence of AM with the outcome of respiratory viral
infection in Csf22/2, Csfrb22/2, Batf32/2, CD11c-Cre/Ppargfl/fl
(with a defect in AM) and wild-type mice. Csf2-deficient mice
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developed severe morbidity and hypersuceptibility to influenza
virus and vaccinia virus infection due to the complete absence of
AM, although CD103+ DC mediated anti-viral T cell responses
were unaffected. In contrast, virus-induced morbidity was
moderately affected in Batf3-deficient mice, which mounted
impaired anti-viral T cell responses due to the absence of
CD8a+ DCs and lung CD103+ DCs. Selective depletion of AM
using clodronate liposomes prior influenza virus infection resulted
in morbidity comparable to Csf2-deficient mice. Moreover, mice
with functionally impaired AM due to conditional deletion of Pparg
showed increased disease severity and respiratory failure despite
normal T cell responses. In contrast, selective postnatal AM
reconstitution in Csfrb22/2mice prevented pulmonary pathology
and morbidity following influenza virus infection. Overall, our
study provides evidence for a vital function of AM for the
maintenance of lung function upon pulmonary viral infections.
Results
Alveolar macrophages fail to develop in the absence of
GM-CSF production by non-hematopoietic cells
Mice lacking GM-CSF (Csf22/2) or the b subunit of its receptor
(Csf2rb2/2) have been reported to develop alveolar proteinosis due
to a defect in terminal maturation and surfactant catabolism of
AM [6,8]. However, AM characterized as CD45+CD11c+Siglec-
F+ cells with high autofluorescence were completely absent in lung
and BAL of adult Csf22/2 mice (Figure 1A, B and Figure S1).
Staining with a viability dye showed a striking enrichment of dead
non-hematopoietic (CD452) cells, presumably consisting mainly of
lung epithelial cells (Figure 1C), indicating that the removal of
dead cells (efferocytosis) in the respiratory tract is impaired in the
absence of AM. Indeed, following tracheal instillation of labeled
apoptotic thymocytes, we found that AM are by far the most
potent cell type compared to DCs and neutrophils in removal of
apoptotic cells from the bronchoalveolar space (Figure 1D and
Figure S1). The few remaining cells that showed up in the
CD11c+Siglec-F+ population of Csf22/2 mice were contaminating
dead cells with high autofluorescence as demonstrated by
comparing the analysis with and without prior exclusion of dead
cells (Figure S1). Absence of AM resulted in the accumulation of
lipoproteinaceous and eosinophilic material in the BAL and lung
of Csf22/2 mice (Figure 1E–G). Moreover, while BAL of WT mice
consisted almost entirely (.90%) of AM, BAL of Csf22/2 mice
contained a substantial proportion of neutrophils (Figure 1H). This
indicates low-grade inflammation possibly induced by the accu-
mulation of dead cells (Figure 1C). Nonetheless, arterial oxygen
saturation in Csf22/2 and WT mice was comparable indicating
unimpaired gas exchange in the lung in the absence of AM under
steady state (Figure 1I).
To determine whether AM require cell intrinsic GM-CSFR
signaling for their development, we generated mixed bone marrow
(BM) chimeras by adoptive transfer of a 1:1 mixture of BM cells
from Csf2rb2/2 (CD45.2+) and WT (CD45.1+) mice (as well as
CD45.2+WT and CD45.1+WT BM as controls). The reconstituted
AM in the BAL and lung of Csf2rb2/2:WT chimeras were
exclusively of WT donor origin and prevented development of
alveolar proteinosis. (Figure 1 J, K and data not shown). In
agreement with a recent report, these data show a requirement of
GM-CSF signaling for the reconstitution of AM post-irradiation
[28].
GM-CSF can be expressed by a variety of different cell types
including T cells, macrophages, mast cells and non-hematopoietic
cells [29]. To assess the source of GM-CSF for the development of
alveolar macrophages, we generated 4-way Csf22/2 and WT
crisscross BM chimeras. Irradiated WT recipients that received
BM from either Csf22/2 or WT mice did not develop any
pulmonary alveolar proteinosis during 16 weeks post-reconstitu-
tion. In contrast, Csf22/2 recipients reconstituted with WT or
Csf22/2 BM showed a massive and comparable proteinosis
(Figure S2). These results identify radio-resistant non-hematopoi-
etic cells such as epithelial cells as the primary source of GM-CSF
in the lung, which is absolutely essential for development of
alveolar macrophages.
Development of lung CD103+ DCs has been reported to
depend on GM-CSF [25]. However, comparing adult WT and
Csf22/2 mice, we found similar numbers of pulmonary CD103+
DCs, although CD103 surface expression on CD11b2CD11c+
DCs was strongly impaired in Csf22/2 mice (Figure 2A–C)
consistent with a previous study using Csf2rb2/2 mice [26].
Interestingly, CD103+ DCs were strongly reduced in 6-day-old
Csf22/2 pups (Figure 2D, E). In addition, injection of BM from
Csf2rb2/2 donors to irradiated WT recipients failed to reconstitute
pulmonary CD103+ DCs (Figure 2F) [25], while other myeloid cell
populations in the lung and peripheral blood were comparably
well reconstituted from Csf2rb2/2 and WT bone marrow cells
(Figure S2). These data suggest that GM-CSF plays an important
role in development of CD103+ DCs, although a population of
CD103lowCD11b2 DCs can substitute typical CD103+ DCs in the
absence of GM-CSF possibly under inflammatory conditions.
Csf22/2 mice have a reduced resistance to influenza
infection despite intact anti-viral T and B cell responses
To determine whether absence of AM and/or impaired
CD103+ DC compartment affect resistance of Csf22/2 mice to
respiratory viral infection, we infected WT and Csf22/2 mice with
a sublethal dose of influenza virus PR8. Compared to WT mice,
Csf22/2 animals showed an earlier onset of disease and a much
more pronounced loss of body weight and body temperature
(Figure 3A, B). Strikingly, whereas all WT mice recovered from
infection, moribund Csf22/2 mice had to be euthanized between
day 10 and 12 post-infection (Figure 3C). Moreover, Csf22/2 mice
showed an increased lung virus titer at the peak of viral load (i.e.
day 6) and a slight delay in viral clearance (Figure 3D), which were
nevertheless to small to explain the moribund state of the Csf22/2
mice. Importantly, the fatal outcome of infection resulted from the
absence of GM-CSF production by non-hematopoietic cells as
demonstrated by a higher susceptibility of WTRCsf22/2 com-
pared to Csf22/2RWT BM chimeras (Figure S3).
Author Summary
Acute respiratory viral infections can cause severe mor-
bidity and pneumonia in infected individuals. Alveolar
macrophages and various subsets of dendritic cells have
been implicated in innate immunity and induction of anti-
viral T cell responses that contribute to host defense
against influenza virus infection. However, their relative
importance in protection from pathology and disease
severity has never been compared side by side. In this
report, we demonstrate that mice lacking alveolar macro-
phages succumb to infection with low dose influenza virus
and vaccinia virus infection due to respiratory failure. In
contrast, mice lacking lymphoid CD8a+ and lung CD103+
DCs survived and showed little if any differences in disease
severity compared to infected wild-type mice. These
results indicate that therapies supporting AM and lung
function may be beneficial during severe respiratory viral
infection.
AM Prevent Asphyxiation during Influenza Virus Infection
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Lung CD103+ DCs have been reported to induce CD8+ T cell
responses by cross-presentation of influenza virus [19,30].
Notably, Csf22/2 mice mounted intact anti-viral CD8+ T cell
effector responses in BAL, lung, and draining LN (Figure 3E, F)
despite a 2-fold reduction in lung CD103+ DC frequencies and
decreased CD103 surface levels during influenza virus infection
Figure 1. Cell-intrinsic requirement of GM-CSF for the development of alveolar macrophages. (A) Identification of live (eFluor7802) AM
(CD45+CD11c+Siglec-F+ autofluorescenthigh) in BAL and lung of WT and Csf22/2 mice. (B) Absolute cell numbers of AM. (C) Quantification of dead
CD452eFluor780+ cells in the BAL. (D) Efferocytosis of i.t. instilled apoptotic thymocytes by indicated populations of myeloid cells. Values shown
depict percentages of efferocytic cells. (E and F) Concentrations of total protein (E) and palmitic acid (F) were measured in the BAL of WT and Csf22/2
mice. (G) Panels show H&E-stained histological lung sections of WT and Csf22/2 mice. (H) Absolute cell numbers of neutrophils (CD11b+CD11c2Gr-1+)
in the BAL. (I) Arterial oxygen saturation in WT and Csf22/2 mice. (J and K) Mixed BM chimeras (1:1 mixture of CD45.1+WT:CD45.2+Csf2rb2/2 or
CD45.1+WT:CD45.2+WT) were analyzed for the contribution of CD45.1 and CD45.2 BM to the development of AM. (J) Dot plots show the percentage
of CD45.1+WT and CD45.2+Csf2rb2/2 (or control CD45.2+WT) cells among CD11c+Siglec-F+ AM in the BAL and lung. (K) Bar graphs display the
frequency of CD45.2+WT and CD45.2+Csf2rb2/2 AM as gated in (J). The mean 6 SD is shown.
doi:10.1371/journal.ppat.1004053.g001
AM Prevent Asphyxiation during Influenza Virus Infection
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(Figure 3G). Nonetheless, total numbers of CD103+ DCs were
similar in Csf22/2 compared to wild-type mice (Figure 3H). In
contrast, influenza virus infected Batf3-deficient mice were almost
entirely devoid of lung CD103+ DCs (Figure 3G, H) and showed a
strong reduction in virus-specific CD8+ T cells and anti-viral
effector cytokine (i.e. TNFa and IFNc) production [19]. Regard-
less, morbidity and disease severity remained almost completely
unaffected in Batf3-deficient compared to wild-type mice, while
Csf22/2 mice succumbed to infection (Figure 3I). Notably, Batf32/
2 mice were able to efficiently clear the virus despite impaired
anti-viral CD8+ T cell responses (Figure S4).
To further characterize the adaptive response and rule out a
possible defect in anti-viral antibody responses in the absence of
GM-CSF, we assessed anti-viral B cell responses by measurement
of influenza HA-specific antibodies. Csf22/2 mice showed
increased levels of virus-specific IgA and IgG2a antibodies in
BAL and serum compared to wild-type mice (Figure S4).
Furthermore, we found similar NK cell recruitment and increased
activation in Csf22/2 compared to wild-type mice (Figure S4).
Together these results demonstrate that CD103+ DC mediated
anti-viral CD8+ T cell responses or B cell responses are intact and
therefore not the underlying reason for the disease severity in
Csf22/2 mice.
AM are crucial for the maintenance of respiratory
function during influenza virus infection
As shown above, absence of AM in mice lacking GM-CSF
results in accumulation of surfactant material and dead cells under
homeostatic conditions. Interestingly, influenza virus infection
strikingly aggravated pulmonary alveolar proteinosis in Csf22/2
mice indicated by an obstruction of alveoli with aggregates of
eosinophilic material (Figure 4A), increased total protein concen-
tration (Figure 4B) and accumulation of surfactant material in the
BAL fluid at days 6 and 10 p.i. (Figure 4C). Moreover, the BAL of
Csf22/2 mice was highly enriched in dead cells and cellular debris
indicating impaired clearance of apoptotic cells (Figure 4D–F).
Accordingly, respiratory function as measured by arterial oxygen
levels was critically impaired at the time when Csf22/2 mice
succumb to infection (Figure 4 G, H). These results suggest that
AM prevent influenza induced morbidity by maintenance of lung
function through removal of dead cells and surfactant material.
Selective restoration of AM development in Csf2rb2/2
mice prevents severe morbidity and mortality following
influenza virus infection
AM were described to maintain independently from blood
monocytes through self-renewal [31]. We and others recently
showed that AM originate from a fetal monocyte precursor in the
lung around E17–19, which subsequently differentiates into
mature AM during the following 5–7 days ([32]; Schneider et
al., unpublished data). Single intranasal transfer of CD45+ lung
cells from E18.5 fetuses into Csf2rb2/2 newborns completely
restored development of mature AM (Figure 5A, B) but did not
contribute to the pool of BM-derived short-lived DCs including
CD103+ DCs 6 weeks after transfer (Figure 5C). Thus, we
generated mice lacking Csf2rb in every cell but AM. Presence of
Figure 2. GM-CSF promotes development of CD103+ DCs and expression of CD103 in young and adult mice, respectively. Analysis of
lung DC subsets in (A–C) 6–8 week-old and (D–E) 6-day-old mice. (A, D) Gated cells in dot plots show CD103+ and CD11b+ DCs with values indicating
percentages among CD11c+Siglec-F2 lung DCs. Cells were pre-gated on CD45+eFluor7802 viable cells. (B,E) Bar graphs depict total number of
CD103+ and CD11b+ DCs in the lung. (C) Mean fluorescence intensity (MFI) of CD103 expression on CD103+CD11b2 DCs. Values shown represent the
mean 6 SD (n = 3–4). (F) Analysis of lung DC subsets in mixed BM chimeras generated by transfer of 1:1 mixture of CD45.1+WT:CD45.2+Csf2rb2/2 or
control CD45.1+WT:CD45.2+WT into lethally irradiated recipients. Bar graphs show the percentage of CD45.2+WT and CD45.2+Csf2rb2/2 cells among
CD103+ and CD11b+ DCs in the lung. The mean 6 SD is shown (n = 3).
doi:10.1371/journal.ppat.1004053.g002
AM Prevent Asphyxiation during Influenza Virus Infection
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Figure 3. Csf22/2 mice succumb to influenza virus infection despite intact antiviral T and B cell responses. (A–I) Indicated groups of
mice were infected i.t. with PR8 influenza virus (50 pfu unless otherwise specified). Loss of body weight (A) and temperature (B) was monitored. (C)
Survival after infection with 100 pfu PR8. Values indicate mean 6 SEM of 8–10 mice per group. (D) Virus titers in the lung at days 6 and 10 p.i. were
measured by plaque-assay. (E–H) Comparison of immune responses in Csf22/2, Batf32/2 and WT mice at day 10 post infection. (E) Percentages (upper
panel) and total numbers (lower panel) of influenza NP34-specific CD8+ T cells in the BAL, lung and lung-draining LN. (F) Virus-specific IFNc and TNFa
production in CD8+ T cells of the BAL, lung and LN was analyzed by restimulation with virus-loaded BMDCs. (G and H) CD103+ DCs in the lung at d10
post-infection were gated on eF7802CD45+CD11c+MHCII+B2202Siglec-F2 cells. Dot plots show the frequencies of CD103+ DCs of individual mice
representative for the group (G) and bar graphs display total numbers (H). Values indicate mean 6 SD of 5–6 mice per group. (I) WT, Csf22/2 and
Batf32/2 mice were monitored for body weight, body temperature and the survival during the course of infection. Data show mean 6 SEM.
doi:10.1371/journal.ppat.1004053.g003
AM Prevent Asphyxiation during Influenza Virus Infection
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wild-type AM in Csf2rb2/2 mice protected from pulmonary
proteinosis, severe morbidity and mortality following influenza
infection (Figure 5 D–F). Moreover, viral load in Csf2rb2/2 mice
with restored AM compartment was reduced to levels observed in
wild type controls (Figure 5G). These results unequivocally
demonstrate that the absence of AM is responsible for disease
severity and rule out a putative contribution of DCs or other
immune cells in mice lacking GM-CSF or its receptor.
Selective AM depletion results in respiratory failure and
increased morbidity following influenza virus infection
To further rule out that a defect in CD103+ DCs contributed to
the susceptibility of Csf22/2 mice to influenza virus infection, we
selectively depleted AM in wild-type mice prior to infection using
clodronate liposomes. Although DC subsets remained unaffected
in clodronate-treated mice (Figure S5), AM-depletion resulted in
increased morbidity (i.e. temperature and weight loss) (Figure 6A,
B) and mortality (Figure 6C), which was associated with hypoxia
(Figure 6D, E) basically resembling the phenotype observed in
Csf22/2 mice. These results further support the conclusion that
absence of AM and respiratory failure rather than impaired
CD103+ DC-mediated CD8+ T cell responses are responsible for
the high morbidity of Csf22/2 mice to influenza virus infection.
To assess whether the AM play an important role in resistance
to other pulmonary viral infections, we assessed the outcome of
infection with vaccinia virus (WR) in Csf22/2 and control WT
mice. Control of vaccinia virus mainly depends on innate and T
helper cell mediated B cell antibody responses, whereas the
cytotoxic T cell response plays only a marginal role [33,34]. When
infected with a virus dose that did not induce any morbidity in WT
mice, Csf22/2 mice showed a pronounced loss of body weight and
temperature (Figure 6F, G) starting already during the innate
immune response at day 4 p.i. and displayed increased lethality
(Figure 6H), reminiscent to the outcome of influenza virus
infection. Altogether, these results establish a direct role of AM
in prevention of fatal respiratory viral infections.
Figure 4. Defective gas exchange and respiratory failure following influenza virus infection in Csf22/2 mice lacking AM. WT and
Csf22/2 mice were infected i.t. with 50 pfu PR8 influenza virus. (A) Panels show H&E-stained histological lung sections of day 10-infected WT and
Csf22/2 mice. The concentration of total protein (B) and cholesterol (C) in the BAL was determined at the indicated time points after infection. (D)
Percentages of dead cells (eFluor780+) and debris (eFluor7802CD452) in the BAL were determined by flow cytometry at d6 and d10. Bar graphs show
the total BAL event number (E) and numbers of eFluor780+ or eFluor7802CD452 events (F). Shown is the mean 6 SD of 4–5 mice per group. Arterial
blood oxygen saturation (G) and O2 partial pressure (H) was measured in infected animals at day 9. Symbols represent values of individual mice and
the mean is shown.
doi:10.1371/journal.ppat.1004053.g004
AM Prevent Asphyxiation during Influenza Virus Infection
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Mice with immature and dysfunctional alveolar
macrophages due to the absence of PPARc show
increased mortality and reduced lung function following
influenza infection
Mice lacking Pparg specifically in macrophages (LysM-Cre/
Ppargfl/fl) develop pulmonary alveolar proteinosis [35]. Moreover,
using CD11c-Cre/Ppargfl/fl mice that lack Pparg in AM and DCs,
we recently found that development of AM is arrested in an
immature state with a defect in surfactant catabolism and lipid
metabolism while development of DC subsets remained unaffected
(data not shown). To determine whether absence of functional AM
affects resistance of CD11c-Cre/Ppargfl/fl mice to respiratory viral
infection, we infected WT and CD11c-Cre/Ppargfl/fl mice with
influenza virus PR8. Compared to WT, CD11c-Cre/Ppargfl/fl mice
showed an earlier onset and more pronounced loss of body weight
and body temperature (Figure 7A, B) associated with increased
lethality (Figure 7C), although lung virus titers were insignificantly
elevated (Figure 7D). Besides a slightly increased number of
neutrophils, recruitment of inflammatory cells to the lung was in
general normal in CD11c-Cre/Ppargfl/fl mice (Figure S6). More-
over, we found similar frequencies and total numbers of anti-viral
CD8+ T cells as well as IFNc-producing CD4+ and CD8+ T cells
(Figure 7E and Figure S6) indicating that DC-mediated T cell
priming and effector responses were unaffected in CD11c-Cre/
Ppargfl/fl mice. Likewise, levels of anti-influenza HA-specific
antibody levels (i.e. IgG2c, IgA and IgG1) were comparable in
BAL and serum of CD11c-Cre/Ppargfl/fl and WT mice (Figure 7F
and Figure S6). Together these results indicate that innate and
adaptive anti-viral immune responses were largely intact in
CD11c-Cre/Ppargfl/fl mice.
Lungs of infected CD11c-Cre/Ppargfl/fl mice contained in-
creased amounts of total protein in BAL fluid with a high
proportion of lipid-engorged foam cells and alveoli filled with
cellular infiltrate and debris (Figure 7G–I and Figure S6).
Moreover, CD11c-Cre/Ppargfl/fl mice displayed significantly lower
lung function as measured by arterial oxygen levels (Figure 7J, K).
Taken together, CD11c-Cre/Ppargfl/fl mice with immature and
dysfunctional AM show increased morbidity and respiratory
failure due to an impaired removal of dead cells and debris
following influenza virus infection similar to, but not as
pronounced as Csf22/2 mice that are completely devoid of AM.
Influenza virus infection potently upregulates expression
of interferon-induced transmembrane protein 3 in
alveolar macrophages
GM-CSF-deficient mice lacking alveolar macrophages showed
5–10-fold increased viral titers and a delayed viral clearance.
Therefore, we next asked whether alveolar macrophages might
contribute directly to viral clearance besides their role in
prevention of respiratory failure following viral infection. Infection
of C57BL/6 mice with PR8 or NS1-GFP influenza virus showed a
considerable proportion of AM containing viral material as
determined by staining of viral NP or expression of NS1-GFP
(Figure 8A, B). In addition, comparison of gene expression profiles
of sorted AM from naı¨ve and influenza virus infected mice by
microarray analysis showed that the latter displayed a typical
Figure 5. Selective restoration of AM development in Csf2rb2/2 mice prevents severe morbidity and mortality following influenza
virus infection. Whole CD45+ cells containing progenitors of AM were sorted from lungs of CD45.1+ E18.5 embryos by flow cytometry and
transferred intranasally into neonatal CD45.2+ Csf2rb2/2 mice. (A) Six weeks after transfer, recipient mice were analyzed for the presence of donor-
derived AM. (B) Bar graphs display the total AM cell number in the BAL and lung. (C) Dot plots depict the expression of CD103 and CD11b on
CD11c+MHCII+Siglec-F2 lung DCs and frequencies of CD45.1+ (donor-derived) and CD45.2+ (recipient-derived) cells among CD103+ DCs are shown.
(D–G) Eight weeks after transfer, recipient mice were infected with 50 pfu PR8 influenza virus. (D) Total protein concentration in the BAL at d5 after
infection. (E) Loss of body weight and temperature and (F) survival was monitored during the course of infection (mean 6 SEM of 6–9 mice per
group). (G) Lung virus titer at day 5 p.i.
doi:10.1371/journal.ppat.1004053.g005
AM Prevent Asphyxiation during Influenza Virus Infection
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interferon signature with a 4- to 65-fold upregulation of several
interferon-induced genes including the interferon-induced trans-
membrane protein 3 (Ifitm3) and Ifitm6, which were upregulated
42- and 9-fold, respectively (Figure 8C). Ifitm3 has recently been
described as a key component in restricting viral spread and the
morbidity and mortality following influenza virus infection [36].
Thus it is tempting to speculate that AM act like a virus sink and
prevent morbidity at least partially through Ifitm3.
Discussion
In this study, we revisited the role of GM-CSF in AM
homeostasis and function of this cell population in respiratory
viral infection. According to the current understanding, Csf2- and
Csf2rb-deficient mice develop pulmonary alveolar proteinosis
(PAP) due to a defect in terminal maturation of AM involving
impaired lipid catabolism. However, using 8-parameter flow
cytometry in combination with dead cell exclusion, we found that
Csf22/2 mice were completely devoid of AM and presented a
massive accumulation of dead CD45-negative cells, which are
presumably epithelial cells, in the BAL and lung consistent with an
important role of AM in removal of dead cells (efferocytosis).
Indeed, usage of a viability dye in combination with CD45 staining
was inevitable for the exclusion of highly auto-fluorescent dead
cells and avoidance of misidentification as AM. We also observed
increased numbers of neutrophils in the BAL of naive Csf22/2
mice supporting an association of impaired efferocytosis and
chronic inflammatory lung disease [37]. Using mixed bone
marrow chimeras we demonstrated that AM exclusively differen-
tiated from WT and not from Csf2rb2/2 BM. The absence of
Csf2rb2/2 AM in mixed BM chimeras also excludes the possibility
that these cells have developed and died subsequently due to a
functional defect in surfactant metabolism and accumulation of
cellular debris, as the mixed chimeras did not develop PAP
pathology. These results demonstrate a cell intrinsic requirement
of GM-CSFR signaling for licensing development of AM from a
precursor cell. Our results are in line with a recent report
Figure 6. Increased morbidity and respiratory failure in mice upon selective depletion of alveolar macrophages prior to pulmonary
virus infection. (A–E) Mice were treated with clodronate or control PBS liposomes 2 days prior to infection with 50 pfu PR8 influenza virus. Loss of
body weight (A) and temperature (B) was monitored. (C) Survival was assessed over a period of 3 weeks after infection. Values indicate mean 6 SEM
of 6 mice per group. Arterial blood oxygen saturation (D) and O2 partial pressure (E) was measured in infected animals at d8. (F–H) WT and Csf2
2/2
mice were infected with 104 pfu vaccinia virus WR i.t. Loss of body weight (F), loss of temperature (G) and survival (H) was monitored. Values indicate
mean 6 SEM of 7–8 mice per group.
doi:10.1371/journal.ppat.1004053.g006
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describing highly reduced numbers of AM in Csf22/2 mice and a
requirement of GM-CSF signaling for the reconstitution of AM
post-irradiation [28]. The license is provided by GM-CSF
secretion of radio-resistant lung cells, as shown by our 4-way
BM chimeras. Whether during homeostasis GM-CSF also
influences the functionality of AM needs to be determined using
inducible knock out strategies or antibody-mediated neutraliza-
tion.
Figure 7. CD11c-Cre/Ppargfl/fl mice have a reduced resistance to influenza virus infection despite an intact antiviral adaptive
response. Ppargfl/fl and CD11c-Cre/Ppargfl/fl mice were infected i.t. with 250 pfu PR8 influenza virus. Loss of body weight (A), temperature (B) and
survival (C) was monitored. Values indicate mean 6 SEM of 9–10 mice per group. (D–K) For the characterization of the anti-viral immune response,
Ppargfl/fl and CD11cCre/Ppargfl/fl mice were infected i.t. with 50 pfu PR8 influenza virus. Symbols represent values of individual mice and the mean is
indicated. (D) The virus titers in the lung were determined at d3, d5 and d9 after infection. (E) Total numbers of influenza NP34-specific CD8+ T cells in
the BAL were analyzed at d10 post-infection. (F) Influenza HA-specific IgG2c antibody concentrations in the BAL at d13 post-infection were
determined by ELISA. Values indicate mean 6 SEM of 4–5 mice per group. (G) Total protein in the BAL was measured at indicated time points. (H)
Cytospins of BAL isolated from infected mice at d9 were stained with Oil Red O. Micrographs were taken at 636magnification. Representative
pictures of 2 individual mice are shown. (I) Panels show lung sections of day 9-infected mice stained using the Verhoeff-Van Gieson protocol. (J and K)
Lung function was measured in naı¨ve and day 9-infected animals. Arterial blood oxygen partial pressure (J) and O2 saturation (K) are shown.
doi:10.1371/journal.ppat.1004053.g007
Figure 8. Influenza infection potently induces expression of interferon-regulated antiviral factors in AM. (A) Mice were infected with
50 pfu PR8 influenza virus. Intracellular NP expression was measured by flow cytometry in CD11c+autofluorescent AM isolated from BAL and lung 5
days after infection. (B) Mice were infected with 106 pfu NS1-GFP virus [51] or 103 pfu PR8. GFP expression was analyzed in AM isolated from BAL and
lung 5 days after infection. (C) Microarray analysis of sorted AM from lungs of naive or influenza-infected animals at d5 post-infection with 50 pfu PR8.
Bar graphs show relative expression levels of various interferon-induced genes plotted as log2-fold change in AM from infected lungs compared to
naı¨ve. The mean of two microarray samples per condition is shown. For each sample, AM from two individual mice were pooled. Differences in
expression levels were validated by qPCR for most of the depicted genes (i.e. Ifitm3, Ifitm6, Ifit2, Ifit3 and Ifi205).
doi:10.1371/journal.ppat.1004053.g008
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The role of GM-CSF for the development of DCs has been
extensively studied. Most lymphoid tissue DCs develop normally
in the absence of GM-CSF in vivo [38]. In contrast, GM-CSF has
been shown to play a pivotal role for the development of non-
lymphoid tissue DCs in the lamina propria [39] and the skin [40].
A recent report suggested that GM-CSF is critical for the
homeostasis of tissue-resident CD103+ DCs in particular in the
lung and skin [25], while others found that GM-CSF merely
regulates CD103 expression levels on DCs and not development of
this DC subset [26]. In keeping with the latter study by Edelson et
al., we found that total CD11b2CD103+ DC cell numbers were
not affected in the lung of adult Csf2-deficient mice, while CD103
surface expression on CD11b2 DCs was clearly reduced.
Interestingly, in lungs of neonatal Csf22/2 mice the CD103+
DC subpopulation was strongly reduced in cell numbers.
Similarly, the vast majority of CD103+ DCs present in lungs of
mixed bone marrow chimeras originated from WT but not
Csf2rb2/2 bone marrow and the few Csf2rb2/2 BM-derived
CD11b2 lung DCs were CD103low. Whether impaired CD103
expression affects DC function is not clear. CD103+ DCs possess a
unique potential in phagocytosis of virus-infected epithelial cells
and capacity in cross-presentation of viral antigens to CD8+ T cells
[41]. Several reports suggested that CD103+ DCs are the main
inducers of CD8+ T cell responses to influenza virus infection with
supportive evidence mainly based on depletion experiment using
langerin-DTR mice [19,30,42]. It should be noted, however, that
langerin is also expressed on CD8a+ DCs from spleen and LNs
[43,44], which are accordingly also depleted in langerin-DTR
mice [45]. Indeed, LN-resident CD8a+ DCs as well as CD11b+
lung tissue DCs have also been implicated in influenza antigen
transport, presentation and CD8+ T cell priming [30,46,47]. Batf3-
deficient mice that are devoid of both CD8a+ DCs and CD103+
DCs showed a substantial reduction in anti-viral CD8+ T cell
responses indicating that both CD8a+ DCs in spleen and lymph
node together with lung migrating CD103+ DCs contribute to the
induction and maintenance of T cell responses to influenza virus.
In contrast, despite an almost 2-fold reduction in frequencies, total
lung CD103+ DC numbers in influenza virus-infected Csf22/2
mice were comparable to wild-type mice and accordingly, antiviral
CD8+ T cell numbers and cytokine responses in the BAL, lung,
and the draining LN remained unaffected. However, the
influenza-induced pathology and morbidity was far worse in
Csf2-deficient mice lacking AM but having intact B and T cell
responses as compared to Batf3-deficient mice with constrained
CD8+ T cell responses due to the absence of both CD103+ DCs
and CD8a+ DCs but intact AM indicating that only the latter are
critical for survival of respiratory viral infection.
PAP was strikingly aggravated in influenza virus infected
compared to naive Csf22/2 mice. The accumulation of cellular
debris, dead epithelial cells and surfactant material in the
respiratory tract in the absence of AM resulted in impaired gas
exchange and eventually in a fatal hypoxia. Similar results were
obtained by clodronate-mediated depletion of macrophages
without affecting DCs in wild-type mice before viral infection. In
keeping with our data, transgenic mice with lung-restricted GM-
CSF overexpression (SPC-GM) and increased AM numbers [48]
were better protected from influenza virus-induced morbidity [24].
However, using the same transgenic mice, another study linked the
GM-CSF-induced protection to enhanced CD103+ DC-mediated
antiviral T cell responses, although numbers of DCs and virus-
specific CD4+ and CD8+ T cells in SPC-GM mice were
comparable to non-transgenic WT mice and the viral load was
significantly reduced as early as day 3 post-infection prior CD8+ T
cell expansion and effector function [27]. Moreover, this study
concluded that increased susceptibility of Csf22/2 mice is a
consequence of defective CD103+ DC-mediated CD8+ T cell
responses [27]. In contrast, protection from virus-induced
pathology and mortality by reconstitution of AM development in
Csf2rb2/2 mice (Figure 5) unequivocally demonstrates that the
absence of AM is the underlying reason for hypersusceptibility to
influenza virus in mice lacking GM-CSF or its receptor. Notably,
Csf22/2 mice showed also increased morbidity and pronounced
lethality in response to pulmonary vaccinia virus infection, which
does not depend on CD8+ T cells [33,34]. These data suggest a
vital role of AM in resistance to respiratory viral infection in
general, although it should be noted that depletion of AM in mice
infected with RSV did not alter subsequent disease develop-
ment[49].
Induction of host cell death is a hallmark of viral infection
including influenza virus infection. Indeed, increased cell death
has been associated with the pathogenicity of highly virulent
influenza virus [50]. Moreover, we found a correlation between
viral burden, PAP, and severity of hypoxia in wild-type mice. Our
findings suggest that the pivotal function of AM is the removal of
dead cells and cellular debris to prevent clogging of the airways
and maintain gas exchange during respiratory viral infection. In
addition, AM may contribute to viral clearance or interfere with
virus-induced morbidity by yet unknown mechanisms. Consistent
with previous reports [51] [19], we found that influenza virus can
directly infect AM (Figure 8A,B). Interestingly, transcriptome
analysis of sorted AM from infected and uninfected mice revealed
a striking upregulation of interferon response signature genes
including high levels of Ifitm3. Ifitm3 has recently been described
as a key component in restricting viral spread and the morbidity
and mortality following influenza virus infection [36]. Moreover,
high Ifitm3 expression in influenza-specific lung-resident CD8+
memory T cells confers resistance to infection and enhances
survival of these cells upon recall infection with the virus [52].
Thus, induction of Ifitm3 in AM could serve as a mechanism to
promote AM survival and thereby limit the loss of this vital cell
type during influenza infection. Furthermore and in addition to
their crucial role in maintaining respiratory function, AM could
have a direct antiviral role serving as a sink for influenza virus
consistent with slightly elevated virus titers in mice lacking AM.
Taken together, we identified a key function of alveolar
macrophages in phagocytosis of dead cells and maintenance lung
function in respiratory viral infections. Mice lacking Csf2 or Csf2rb
are highly vulnerable to influenza virus infection due to the
absence of AM but not potentially impaired DC/T cell immunity.
These results have implications for therapies targeting Csf2 (GM-
CSF).
Materials and Methods
Mice
Csf22/2 mice (originally kindly provided by A. Dunn, Ludwig
Institute for Cancer Research, Royal Melbourne Hospital,
Victoria, Australia) [7] were backcrossed to BALB/c for 7
generations [53]. Csf22/2 (C57BL/6) and Csf2rb2/2 (C57BL/6)
mice were kindly provided by B. Becher (University Zurich).
C57BL/6 and BALB/c mice were purchased from Charles River
(Germany). It should be noted that most of the results shown were
done with Csf22/2 (C57BL/6) and validated with Csf22/2
(BALB/c). B6.129S(C)-Batf3tm1Kmm/J (Batf32/2) mice [54] were
purchased from the Jackson Laboratory. Ppargfl/fl mice [55]
originally kindly provided by P. Chambon (Universite´ Louis
Pasteur, Illkirch Cedex, France) and backcrossed for 6 generations
to C57BL/6 before crossing to CD11c-Cre [56] mice in our
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facility to generate CD11c-Cre/Ppargfl/fl mice. All animals were
housed in individually ventilated cages under specific pathogen
free conditions at BioSupport AG (Zurich, Switzerland) and used
for experiments at between 8 and 12 weeks of age.
Ethics statement. All animal experiments were approved by
the local animal ethics committee (Kantonales Veterina¨rsamt
Zu¨rich, licenses 167/2011 and 113/2012), and performed
according to local guidelines (TschV, Zurich) and the Swiss
animal protection law (TschG).
Cells suspension preparations
Mice were sacrificed by an overdose of pentobarbital sodium
i.p. BAL was isolated by canalization of the trachea with a
catheter. The lungs were flushed with 36400 ml PBS and BAL
cells were harvested by centrifugation. Lungs were digested with
2 mg/ml of type IV collagenase (Worthington) and 0.02 mg/ml
DNaseI (Sigma) at 37uC for 45 minutes and subsequently passed
through a 70 mm cell strainer.
Flow cytometry
Multiparameter analysis was performed on a FACSCanto II or
LSR Fortessa (BD) and analyzed with FlowJo software (Tree Star).
Monoclonal antibodies specific to mouse CD11c (N418), CD11b
(M1/70), Ly-6C (HK1.4), Siglec-F (E50-2440, BD Biosciences),
CD103 (2E7), CD115 (AFS98, eBioscience), CD45 (30-F11),
CD45.1 (A20), CD45.2 (104), CD4 (GK1.5), CD8a (53-6.7),
MHC class II (M5/114.15.2, eBioscience), Gr-1 (RB6-8C5,
eBioscience), CD49b (DX5, eBioscience), CD69 (H1.2F3), TNF-
a (MP6-XT22), IFN-c (XMG1.1) were purchased from Biolegend
unless otherwise stated. Dead cells were stained using eFluor780
(eBioscience). PE-conjugated peptide-MHC class I tetramers (H-
2Db/NP34) with the peptide NP34 (NP366-374; ASNENMETM)
from the nucleoprotein of influenza virus A/PR/8/34 were
generated as described [57]. For detection of intracellular NP
expression, cells were incubated with a monoclonal mouse anti-
influenza NP antibody (HB-65, homemade) followed by staining
with AF647-conjugated anti-mouse IgG (Life Technologies Co.).
Prior to all stainings, FccIII/II receptors were blocked by
incubation with homemade anti-CD16/32 (2.4G2).
Phagocytosis of apoptotic cells
Thymocytes were isolated from C57BL/6 mice and apoptosis
was induced by exposure to 60 mJ UV radiation (Spectrolinker
XL-1500; Spectronics Corporation). After 2 h incubation at 37uC
in IMDM+10% FCS, cells were labeled with 5 mM eFluor670
(eBioscience) according to the manufacturer’s instructions, washed
extensively with IMDM+10% FCS and delivered i.t. in PBS. 3 and
24 h after administration, efferocytosis by cells in the BAL and
lung was assessed by flow cytometry.
Bone marrow chimeras
For mixed bone marrow chimeras, CD45.1+CD45.2+ mice
were lethally irradiated (9.5 Gy, using a caesium source) and
reconstituted with 5–106106 BM cells of a 1:1 mixture of
CD45.1+WT:CD45.2+WT or CD45.1+WT:CD45.2+Csf2rb2/2.
Mice were analysed 10 weeks post-reconstitution. For 4-way
Csf22/2/WT bone marrow chimeras, WT and Csf22/2 mice
were lethally irradiated and reconstituted with 5–106106 Csf22/2
or WT BM cells. Mice were analysed 16 weeks post-reconstitution.
BAL protein and fatty acid analysis
Total BAL protein concentration was measured by BCA
Protein Assay (Thermo Scientific) according to the manufacturer’s
instructions. For fatty acid analysis, BAL lipids were extracted as
described by Moser et. al [58] using methanol-methylene chloride
(3:1, v/v). Thereafter, two internal standards, deuterated C17:0
(Cambridge Isotope Laboratories, Inc., Andover, MA, USA) and
deuterated C22:0 (Dr. Ehrenstorfer GmbH, Augsburg, Ger-
many) were added to the samples. Derivatization was done by
adding acetyl chloride followed by an incubation at 100uC for
1 h. The reaction was stopped with 7% K2CO3 and the
extraction of fatty acid methyl esters was performed with hexane.
After centrifugation for 20 min at 2500 rpm, the hexane layer
was dried under a continuous nitrogen stream and resuspended
in heptane. For the fatty acid analysis, gas chromatography-mass
spectrometry was applied using a Finnigan PolarisQ ion trap gas
chromatography-mass spectrometry system (Thermo Quest,
Austin, TX, USA). For quantification of fatty acid methyl esters,
the specific masses were extracted. Analytes were identified with
authentic standards by comparison of their retention time and
their mass spectrum.
Viruses and infection
Influenza virus strain PR8 (A/Puerto Rico/34, H1N1) was
originally provided by J. Pavlovic, University Zurich. The
influenza strain PR8 NS1-GFP carrying a GFP reporter in the
NS segment was kindly provided by A. Garcı´a-Sastre [51].
Vaccinia virus WR was kindly provided by J. Mercer, ETH
Zurich. For infections, the mice were anaesthetized and
intratracheally inoculated with indicated doses of virus in 50 ml
endotoxin-free PBS. To determine influenza virus titers in the
lungs, samples were collected on various days after infection,
homogenized and serially diluted with MDCK cells as described
[59]. Infected cells were detected using a monoclonal mouse
anti-influenza NP antibody (HB-65, homemade). For the
depletion of AM, mice were treated with 100 ml clodronate
liposomes i.t. 2 days prior to infection. Clodronate was a gift
from Roche Diagnostics GmbH and liposomes were prepared as
previously described [60]. Control mice were treated with PBS
liposomes.
In vitro stimulation
For restimulation, 1.56105 bone marrow-derived dendritic cells
(BMDC) were incubated overnight with 16106 pfu UV-inactivat-
ed PR8 virus in 96-well plates. BMDC were pulsed with 1 mg/mL
NP147 (Balb/c) or NP34 (C57BL/6) peptide for 2 hours before
BAL, lung or LN cells from individual mice were added and
restimulation was performed for 4–5 h in the presence of 2 mM
monensin (Sigma-Aldrich). After surface staining and formalin-
fixation, intracellular cytokine staining was done in the presence of
0.5% saponin using anti-mouse TNF-a FITC and IFN-c APC and
analysed by flow cytometry.
Detection of virus-specific antibodies
Serum or BAL fluid from indicated time points post-infection
was measured for influenza HA-specific antibody levels. Ninety-six
well plates (Maxisorp; Nunc) were coated with 5 mg/ml recom-
binant PR8 influenza virus HA (a kind gift of M. Bachmann,
Cytos) in PBS overnight at 4uC. After blocking, serum and BAL
fluid from individual mice were serially diluted and incubated at
RT for 2 hours. Plates were washed and incubated with alkaline-
phosphatase-labelled goat anti-mouse isotype-specific antibodies
(Southern Biotech Technologies, Inc.) and developed using
substrate p-nitrophenyl phosphate (Sigma-Aldrich). Optical den-
sities were measured on an enzyme-linked immunosorbent assay
reader (Bucher Biotec) at 405 nm.
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Measurement of arterial oxygen saturation
The femoral artery was catheterized in anaesthetized (2%
isoflurane in oxygen) mice and the wound was locally anaesthetized
by the application of 2% lidocaine before the cut was closed and the
catheter was sewn to the thigh to be held in place. The application of
isoflurane was stopped and mice regained consciousness and were
kept restrained in a dark card tube while normally breathing room
air for 10 min to equilibrate blood gas. Subsequently, 100 mL
arterial blood was taken from the catheter and blood gas
composition was measured on an ABL800Flex blood gas analyzer
(Radiometer, Denmark) before mice were sacrificed.
Lung histology
The lungs were removed, fixed in formalin and processed for
Hematoxylin and Eosin (H&E) staining. Histological sections were
evaluated according to general inflammation.
Cell sorting and transfer
Fetal CD45+ cells were sorted from the lungs of CD45.1+ wild-
type E18.5 fetuses using a FACSAria IIIu (BD). Neonatal
Csf2rb2/2 recipient mice were anesthetized using Isoflurane and
16105 fetal cells were administered i.n. in 10 ml PBS. Reconsti-
tution of AM in the BAL and lung was assessed by flow cytometry
6 weeks post-transfer and mice were used for infection experiments
at 8 weeks of age.
Microarray analysis
Lungs of naive or influenza-infected animals at d5 post-infection
were processed as described and stained with eF780, anti-mouse
CD45, CD11c, CD11b and Siglec-F. AM were sorted as
eF7802CD45+CD11chighautofluorescencehighSiglec-F+ (BD FAC-
SAria IIIu) and RNA was prepared using PureLink RNA Mini Kit
(ambion, Life Technologies Co.), amplified and hybridized on the
Affymetrix Mouse Gene 1.1 ST.
Statistical analysis
Mean values, SD, SEM, and Student’s t test (unpaired) were
calculated with Prism (GraphPad Software, Inc). p,0.05 (*), p,
0.01 (**), p,0.001 (***), p,0.0001 (****).
Supporting Information
Figure S1 Alveolar macrophages are the predominant
efferocytic cell population in the bronchoalveolar space
and are completely absent in Csf22/2mice. (A) Dot plots
depict identification of AM as CD11c+Siglec-F+ cells with high
auto-fluorescence and assessment of viability using the viability dye
eFluor780 (that labels dead cells) in BAL and lung of Csf22/2 and
WT mice. Note that the few remaining CD11c+Siglec-F+ cells in
Csf22/2 mice are all dead hematopoietic cells with high
fluorescence. A maximal amount of 20’000 events per plot is
depicted. (B and C) C57BL/6 mice were inoculated i.t. with
eFluor670-labeled apoptotic thymocytes. BAL and lung cells were
isolated 3 and 24 h later and analyzed by flow cytometry. (B) Dot
plots show the frequencies of AM among all eFluor670+ efferocytic
cells in the lung. (C) Percentages of eFluor670+ cells among AM in
the lung. Representative samples are shown (n = 4).
(EPS)
Figure S2 GM-CSF produced by radio-resistant cells
drives development of alveolar macrophages. (A–C)
Pulmonary alveolar proteinosis in WTRWT, WTRCsf22/2,
Csf22/2RWT and Csf22/2RCsf22/2 BM chimeras was assessed
by measurement of BAL total protein (B), palmitic acid (C) and
cholesterol concentration (D). Bar graphs represent the mean6 SD
(WTRWT, n = 4; WTRCsf22/2, n = 3; Csf22/2RWT, n = 3;
Csf22/2RCsf22/2, n = 1). (D) Mixed BM chimeras (described in
Figure 1 J and K) were analyzed for the contribution of CD45.1 and
CD45.2 BM to the development of lung CD11c2CD11b+ and
blood myeloid subsets. The mean 6 SD is shown (n = 3).
(EPS)
Figure S3 GM-CSF produced by radio-resistant cells is
crucial for resistance to influenza infection. (A and B)
WTRWT, WTRCsf22/2, Csf22/2RWT and Csf22/2RCsf22/2
BM chimeric mice were infected i.t. with 50 pfu PR8 influenza
virus. Loss of body temperature (A) and survival (B) was monitored.
Values indicate mean 6 SEM (WTRWT, n = 3; WTRCsf22/2,
n = 6; Csf22/2RWT, n = 5; Csf22/2RCsf22/2, n = 6).
(EPS)
Figure S4 Intact anti-viral B and NK cell responses in
Csf22/2 mice. WT, Csf22/2 and Batf32/2 mice were infected
i.t. with 50 pfu PR8 influenza virus. (A) The virus titers in the lung
at d5 and d13 after infection were measured by plaque-assay. (B)
Influenza HA-specific antibody levels of the indicated Ig isotypes
in the BAL and serum of WT and Csf22/2 mice at d10 after
infection were determined by ELISA. (C and D) Bar graphs
display total numbers of DX5+ NK cells (C) and frequencies of
CD69+DX5+ cells (D) at day 3 and 5 post-infection. Values
indicate mean 6 SD of 3–5 mice per group.
(EPS)
Figure S5 Clodronate treatment selectively depletes AM.
(A–E) Lungs of mice treated with clodronate liposomes were analysed
for AM and CD103+ DCs 2 days after treatment. (A) Plots show
frequencies of AM in the BAL and lung gated on eF7802CD45+
cells. Bar graphs display total cell numbers of AM in BAL (B) and
lung (C). (D and E) Frequencies (D) and total cell numbers (E) of
CD103+ and CD11b+ DCs among CD11c+Siglec-F2 cells in the lung
are shown. Bar graphs represent the mean 6 SD (n = 4).
(EPS)
Figure S6 Lung inflammatory infiltrate and adaptive
immune responses in CD11cCre/Ppargfl/fl mice infect-
ed with influenza virus. CD11cCre/Ppargfl/fl and control
Ppargfl/fl mice were infected i.t. with 50 pfu PR8 influenza virus.
(A) Differential cell composition in the BAL was assessed by flow
cytometry at d6 post-infection. (B–D) Anti-viral T cell response
was analyzed at d10 post-infection. Total numbers of influenza
NP34-specific CD8+ T cells in the lung-draining lymph node (B)
and frequencies in the BAL (C) were measured (mean 6 SD,
n = 5). (D) IFN-c production in BAL CD8+ and CD4+ T cells was
analyzed by virus-specific restimulation. (E) Influenza HA-specific
antibody concentrations of the indicated isotypes in the BAL and
serum were determined by ELISA. (F) Percentages of oil red O+
cells quantified cytospins of the BAL at d9 after infection. Symbols
represent values of individual mice and the mean is indicated. Bar
graphs show the mean 6 SD of 5 mice per group.
(EPS)
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